The UK DRI is made up of people who choose to take the road less travelled, and we run schemes to encourage and reward this. This spring, we launched our ‘Pilot Studies Programme’ and today we're pleased to announce the five successful UK DRI applications that have been selected.
Designed to inspire UK DRI post-docs to consider new avenues of research aimed at understanding or treating neurodegenerative diseases, the Pilot Studies Programme awards up to £44K in direct costs for a 1-year project.
Seventeen post-docs from across the institute came forward with fantastic ideas, and we’re thrilled to share the details of the projects which sung the loudest:
- Dr Bhuvaneish.T.Selvaraj, UK DRI at Edinburgh
C9ORF72 astrocytes mediated transcriptome dysregulation in motor neurons
- Dr Carola Radulescu & Dr Amy Smith, UK DRI at Imperial
Discovery of the integrated optogenetic-transcriptomic signatures of destabilised neuronal activity early in progression of an Alzheimer’s disease model
- Dr Jana Hartmann, UK DRI at UCL
A novel GABAergic agonist for the prevention and treatment of Alzheimer’s disease
- Dr Edward Rhodes & Dr Robert Peach, UK DRI at Imperial
Closed-loop, phase-locked peripheral stimulation as a neuromodulatory intervention for Parkinson’s disease
- Dr Suman De, UK DRI at Cambridge
ApoE/Amyloid-β coaggregates: A potential therapeutic target for ApoE4 mediated Alzheimer’s disease
Applications were judged on the basis of scientific merit, novelty and the value of the project in obtaining preliminary data that could lead to subsequent major external funding opportunities.